| Date | Title | Description |
| 16.04.2024 | Health | As AI eye exams prove their worth, lessons for future tech emerge | Hannah Norman | (TNS) KFF Health News
Christian Espinoza, director of a Southern California drug-treatment provider, recently began employing a powerful new assistant: an artificial intelligence algorithm that can perform eye exams with pic... |
| 23.06.2023 | New FDA Clearance Makes Eyenuk the First Company with Multiple Cameras for Autonomous AI Detection of Diabetic Retinopathy | Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in real-world applications for AI Eye Screening and AI Predictive Biomarkers, adding to the already-cleared usage with Canon CR-2 AF and Canon CR-2 Plus AF... |
| 01.02.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 1st Feb 2023 | This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and hu... |
| 31.01.2023 | Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma | The approval allows Eyenuk’s AI eye screening system, already approved for detection of diabetic retinopathy, to aid millions of additional patients at risk for vision loss
Eyenuk, a global artificial intelligence (AI) digital health compan... |
| 18.10.2022 | Los Angeles-based digital health company Eyenuk raises USD 26 million in Series A funding | LOS ANGELES, Oct. 17, 2022 — Eyenuk, Inc. , a global artificial intelligence (AI) digital health company and the leader in real-world applications for AI Eye ScreeningTM and AI Predictive BiomarkersTM, today announced a Series A financing r... |
| 17.10.2022 | Eyenuk Raises $26M in Series A Funding | Eyenuk, a Los Angeles, CA-based artificial intelligence (AI) digital health company, raised $26M in Series A funding.
The round, which brings total funding to over $43m, was led by AXA IM Alts with participation from T&W Medical A/S, A&... |
| 17.10.2022 | AI-powered eye screening platform Eyenuk raises $25M | Photo: FG Trade/Getty Images |
| 17.10.2022 | Eyenuk Raises $26M for AI-Powered Eye Screening & Predictive Biomarkers | What You Should Know:
Eyenuk, Inc. is a global artificial intelligence (AI) digital health company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease... |
| 17.10.2022 | Eyenuk Secures $26 Million Series A |
LOS ANGELES, CA, Eyenuk, a global artificial intelligence (AI) digital health company, has secured $26 million in a Series A financing round.
>> Click here for more funding data on Eyenuk
>> To export Eyenuk funding data to ... |
| 17.10.2022 | Eyenuk raises $26M for diabetic retinopathy screening tech | Eyenuk, a Los Angeles company that makes technology for eye screenings, raised $26 million on Monday in a Series A funding round. The round, led by AXA IM Alts, brings Eyenuk’s total funding to more than $43 million.
The company was founded... |
| 17.10.2022 | Eyenuk Secures $26 Million Series A Funding to Accelerate Global Access to AI-Powered Eye-screening Technology | Eyenuk, Inc., a global artificial intelligence (AI) digital health company and the leader in real-world applications for AI Eye Screening and AI Predictive Biomarkers, announced it has secured $26 million in a Series A financing round, brin... |
| 17.10.2022 | Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology | Brings Eyenuk's total funding to over $43 million
Funding round led by AXA IM Alts; joined by T&W Medica A/S, Kendall Capital Partners, and others
Eyenuk adds three new board members
Funding affirms Eyenuk's standing as the global leade... |
| 17.10.2022 | AI-based eye screening platform Eyenuk raises $25M | The company is starting with diabetic retinopathy but plans to expand to other conditions as well
Diabetic retinopathy is the leading cause of blindness in adults; if detected early, it's completely preventable but millions don't get the ne... |
| 10.03.2022 | Population Health Alliance Welcomes Eyenuk as Its Newest Member | WASHINGTON (PRWEB) March 10, 2022
Population Health Alliance (PHA), the industry’s only multi-stakeholder professional and trade association solely focused on population health, announced today that Eyenuk, Inc. has joined the organization ... |
| 07.08.2021 | Venture Cash Is Pouring Into AI that Can Diagnose Diseases. Doctors Aren’t Sure They Can Trust It. | Medical imaging AI, which can help diagnose health problems doctors don't always see, is only getting more sophisticated—and more lucrative. Just last month, Tel Aviv-based Aidoc raised $65 million for its AI-powered medical imaging platfor... |
| 26.07.2021 | Eyenuk Raises $6.2M in Funding | Eyenuk, a Los Angeles CA-based artificial intelligence (AI) medical technology and services company, raised $6.2M in funding.
The round was led by AXA IM, through AXA IM Alts.
The company intends to use the funds to accelerate commercializa... |
| 21.07.2021 | Eyenuk Announces $6.2 Million Financing To Accelerate Adoption Of FDA-Cleared AI Technology For Detection Of Diabetic Retinopathy | Financing led by AXA IM’s Impact Investing strategy
Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, today announced that it has comp... |
| 20.07.2021 | Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy | LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, today announced that it has completed... |
| 02.04.2020 | Eyenuk Reports Strong First Quarter 2020 Commercial Results | Preparing for Accelerated Business Growth Ahead
LOS ANGELES–(BUSINESS WIRE)–April 2, 2020–
Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Scre... |
| 21.01.2020 | Leading Medical Retina Center in Italy Adopts Eyenuk’s EyeArt AI Eye Screening System | University of Genoa Team Presented Strong EyeArt Results at the Macula in Liguria 2020 Conference
LOS ANGELES–(BUSINESS WIRE)–January 21, 2020–
Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and t... |
| 28.12.2015 | HealPros wants to address diabetes complications such as diabetic retinopathy through mobile eye exams | HealPros gives mobile diabetic eye exams in member’s homes, primary care practices, health centers, and other venues, according to the statement.
There are a few companies developing diabetes retinopathy tools to make screenings more access... |
| - | HealPros wants to address diabetes complications such as diabetic retinopathy through mobile eye exams | Even as the rate of new cases of Type 2 diabetes declines, this patient population risks developing complications from the chronic condition. One of them is diabetic retinopathy, which can cause blindness. A digital health startup developin... |
| - | Medicare prices AI-based screening for diabetic retinopathy | The Centers for Medicare and Medicaid Services (CMS) will cover an autonomous screening tool and allow it to count toward quality measures. As part of its 2022 Medicare Physician Fee Schedule, CMS set a national payment amount for using AI ... |
| - | Eyenuk, Inc. | “Harnessing deep learning to prevent blindness Learn how Eyenuk can help Eyenuk Featured in Medical Tribune Article March 28, 2022 March 28, 2022 – Eyenuk was recently featured in a Medical Tribune article highlighting the” |
